Rapport Therapeutics, Inc.
NASDAQRAPP has had a remarkable week — the stock jumped 15.7% to $48.82, short sellers retreated sharply, and options positioning flipped to its most bullish reading in months. The clearest driver of this week's move is short covering. Short interest dropped 24% over the past week alone, falling to 4.5% of free float — the lowest level in the 30-day window. From a peak near 2.81 million…
RAPP short interest fell 24% over one week to 4.5% of float, as stock rallied 16% on clinical momentum in epilepsy and bipolar mania programs.
Snapshot as of 12 Aug 2026
RAPP has had a remarkable week — the stock jumped 15.7% to $48.82, short sellers retreated sharply, and options positioning flipped to its most bullish reading in months. The clearest driver of this week's move is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RAPP — free to start on ORTEX.
Sign up for free →Open RAPP on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live RAPP data →